Imagine
The potential of medical innovation is limitless. If Europe fully seizes this opportunity, just imagine what we could achieve
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 15.05.24
Patient involvement in HTA (Guest blog)
Health Technology Assessments: What can we learn from experiences across Europe?
Read Article -
Blog articles 14.05.24
Advancing Clinical Trials for European Patients
Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for clinical research.
Read Article -
Statements & press releases 13.05.24
Joint business statement on the EU Proposal on Compulsory Licensing
We believe that, in its current form, this initiative will undermine innovation and competitiveness of European companies, ultimately impeding Europe's...
Read Article -
Partner Event 27.05.24
Five ways to reduce cancer care inequalities in Europe: Looking beyond the elections.
From May 27th to May 31st, 2024, CPE will host a series of daily 45 minute webinars addressing actionable steps to reduce cancer care inequalities in Europe...
View Event -
Partner Event 31.05.24
IMI impact on antimicrobial resistance
Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects.
View Event -
EFPIA Event 04.06.24
Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?
In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at the EU level.
View Event